Kadmon Holdings, Inc. | Business Contracts

First Supplemental Indenture, dated as of November 9, 2021, by and between Kadmon Holdings, Inc. and U.S. Bank National Association, as Trustee (Filed With SEC on November 9, 2021)

Second Amendment to Employment Agreement between Kadmon Corporation, LLC and Gregory S. Moss, dated September 7, 2021 (Filed With SEC on September 8, 2021)

Second Amendment to Employment Agreement between Kadmon Corporation, LLC and Steven Meehan, dated September 7, 2021 (Filed With SEC on September 8, 2021)

Second Amendment to Employment Agreement between Kadmon Corporation, LLC and Harlan W. Waksal, M.D., dated September 7, 2021 (Filed With SEC on September 8, 2021)

Agreement and Plan of Merger, dated as of September 7, 2021, by and among Kadmon Holdings, Inc., Sanofi and Latour Merger Sub, Inc (Filed With SEC on September 8, 2021)

Amended and Restated Kadmon Holdings, Inc. 2016 Equity Incentive Plan (Filed With SEC on May 12, 2021)

Antibody License Agreement, dated July 22, 2011, between Dyax Corp. and Kadmon Pharmaceuticals, LLC (Filed With SEC on March 4, 2021)

1st Amendment to the Antibody Library License Agreement dated July 22, 2015, between Dyax Corp. and Kadmon Pharmaceuticals, LLC (Filed With SEC on March 4, 2021)

Amendment to Employment Agreement between Kadmon Corporation, LLC and Harlan W. Waksal, effective January 1, 2021 (Filed With SEC on March 4, 2021)

Amendment to Employment Agreement between Kadmon Corporation, LLC and Steven Meehan, effective January 1, 2021 (Filed With SEC on March 4, 2021)

Amendment to Employment Agreement between Kadmon Corporation, LLC and Gregory S. Moss, effective January 1, 2021 (Filed With SEC on March 4, 2021)

Description of the Companys Common Stock (Filed With SEC on March 4, 2021)

Employment Agreement between Kadmon Corporation, LLC and Harlan W. Waksal, M.D., dated effective as of January 1, 2020 (Filed With SEC on March 5, 2020)

Description of the Companys Common Stock (Filed With SEC on March 5, 2020)

Underwriting Agreement, dated November 13, 2019, by and among Kadmon Holdings, Inc., Jefferies LLC and Cantor Fitzgerald & Co., as representatives of the underwriters listed... (Filed With SEC on November 14, 2019)

Employment Agreement between Kadmon Corporation, LLC and Gregory S. Moss, effective as of August 30, 2019 (Filed With SEC on November 7, 2019)

Separation Agreement and General Release between Kadmon Corporation, LLC and Steven N. Gordon, effective as of August 30, 2019 (Filed With SEC on November 7, 2019)

Employment Agreement between Kadmon Corporation, LLC and Steven Meehan, dated effective as of February 8, 2019 (Filed With SEC on May 9, 2019)

Separation and Release Agreement between Kadmon Corporation, LLC and Konstantin Poukalov, dated November 30, 2018 (Filed With SEC on March 7, 2019)

Form of Performance Stock Option Agreement under Amended and Restated Kadmon Holdings, Inc. 2016 Equity Incentive Plan (Filed With SEC on March 7, 2019)

Sixth Waiver Agreement to Credit Agreement, dated March 6, 2019, by and among Kadmon Pharmaceuticals, LLC, the guarantors party thereto and Perceptive Credit Holdings, L.P (Filed With SEC on March 7, 2019)

Amendment # 5 to Credit Agreement and Amendment to Warrant Certificate, dated August 15, 2018, by and among Kadmon Pharmaceuticals, LLC, the guarantors from time to time party... (Filed With SEC on August 16, 2018)

Underwriting Agreement, dated June 11, 2018, by and among the Company and Jefferies LLC, as representative of the underwriters listed therein (Filed With SEC on June 14, 2018)

Form of Subscription Agreement, dated June 11, 2018 (Filed With SEC on June 14, 2018)

Amendment # 4 to Credit Agreement, dated June 12, 2018, by and among Kadmon Pharmaceuticals, LLC, the guarantors from time to time party thereto, the lenders from time to time... (Filed With SEC on June 13, 2018)

Amended and Restated Kadmon Holdings, Inc. 2016 Employee Stock Purchase Plan (Filed With SEC on May 8, 2018)

Form of Performance Stock Option Award Agreement under Amended and Restated Kadmon Holdings, Inc. 2016 Equity Incentive Plan (Filed With SEC on April 9, 2018)

Amended and Restated Kadmon Holdings, Inc. 2016 Equity Incentive Plan (Filed With SEC on March 6, 2018)

Form of Stock Appreciation Right Agreement under Amended and Restated Kadmon Holdings, Inc. 2016 Equity Incentive Plan (Filed With SEC on March 6, 2018)

Fifth Waiver Agreement to Credit Agreement, dated March 2, 2018, by and among Kadmon Pharmaceuticals, LLC, the guarantors from time to time party thereto, the lenders from time to... (Filed With SEC on March 6, 2018)

Form of Subscription Agreement, dated September 26, 2017 (Filed With SEC on September 28, 2017)

Form of Warrant Agreement (Filed With SEC on September 28, 2017)

Underwriting Agreement, dated September 26, 2017, by and among the Company and Jefferies LLC and Piper Jaffray & Co., as representatives of the several underwriters listed therein (Filed With SEC on September 28, 2017)

SIXTH Amendment to Lease (Filed With SEC on August 14, 2017)

FIFTH Amendment to Lease (Filed With SEC on August 14, 2017)

AMENDMENT #3 TO CREDIT AGREEMENT AND AMENDMENT TO WARRANT CERTIFICATES (Filed With SEC on April 3, 2017)

SECOND AMENDMENT TO SUPPLY AND DISTRIBUTION AGREEMENT (Filed With SEC on March 22, 2017)

KADMON HOLDINGS, INC. 2016 EQUITY INCENTIVE PLAN TABLE OF CONTENTS (Filed With SEC on March 22, 2017)

KADMON HOLDINGS, INC. 2016 EMPLOYEE STOCK PURCHASE PLAN TABLE OF CONTENTS (Filed With SEC on March 22, 2017)

THIRD AMENDMENT TO SUPPLY AND DISTRIBUTION AGREEMENT (Filed With SEC on March 22, 2017)

FOURTH WAIVER AGREEMENT TO CREDIT AGREEMENT (Filed With SEC on March 22, 2017)

[FORM OF WARRANT] (Filed With SEC on March 9, 2017)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 9, 2017)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 9, 2017)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 8, 2017)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 8, 2017)

[FORM OF WARRANT] (Filed With SEC on March 8, 2017)

THIRD WAIVER AGREEMENT TO CREDIT AGREEMENT (Filed With SEC on November 9, 2016)

AMENDMENT #2 TO CREDIT AGREEMENT (Filed With SEC on November 9, 2016)

KADMON HOLDINGS, INC. REGISTRATION RIGHTS AGREEMENT (Filed With SEC on August 1, 2016)

KADMON HOLDINGS, INC. 2016 EQUITY INCENTIVE PLAN (Filed With SEC on July 26, 2016)

KADMON HOLDINGS, INC. 2016 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on July 26, 2016)

FIRST AMENDMENT TO ASSET PURCHASE AGREEMENT AS OF JUNE 20, 2008 BETWEEN ZYDUS PHARMACEUTICALS USA, INC., CADILA HEALTHCARE LIMITED D/B/A ZYDUS CADILA AND KADMON PHARMACEUTICALS,... (Filed With SEC on July 7, 2016)

EXCHANGE AGREEMENT BY AND AMONG KADMON HOLDINGS, LLC, KADMON PHARMACEUTICALS, LLC AND THE INVESTORS LISTED ON ANNEX I June 8, 2016 (Filed With SEC on July 7, 2016)

KADMON HOLDINGS, INC. REGISTRATION RIGHTS AGREEMENT (Filed With SEC on July 7, 2016)

KADMON HOLDINGS, LLC REGISTRATION RIGHTS AGREEMENT (Filed With SEC on July 7, 2016)

Kadmon Holdings, LLC 450 East 29thStreet New York, New York 10016 (Filed With SEC on July 7, 2016)

ASSET PURCHASE AGREEMENT between ZYDUS PHARMACEUTICALS USA, INC. and CADILA HEALTHCARE LIMITED D/B/A and THREE RIVERS PHARMACEUTICALS, LLC Dated: June 20, 2008 (Filed With SEC on July 7, 2016)

ASSET PURCHASE AGREEMENT (Filed With SEC on July 7, 2016)

confidential (Filed With SEC on July 7, 2016)

PLAN OF CONVERSION Converting KADMON HOLDINGS, LLC (a Delaware limited liability company) into KADMON HOLDINGS, INC. (a Delaware corporation) (Filed With SEC on July 7, 2016)

Kadmon Holdings, Inc. (61)